Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) shot up 3.3% during trading on Monday . The company traded as high as $2.8647 and last traded at $2.85. 8,898 shares were traded during mid-day trading, a decline of 99% from the average session volume of 1,049,645 shares. The stock had previously closed at $2.76.
Virios Therapeutics Trading Up 3.9%
The company has a fifty day moving average price of $3.23 and a two-hundred day moving average price of $4.85. The firm has a market capitalization of $56.43 million, a price-to-earnings ratio of -10.85 and a beta of 1.58.
About Virios Therapeutics
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
See Also
- Five stocks we like better than Virios Therapeutics
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- June 30th. The deadline Congress buried on page 847.
- 3 Signs You May Want to Switch Financial Advisors
- Your name isn’t on our protected list yet
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
